3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
19
Lymphoma
5
Lung Neoplasms
5
Multiple Myeloma
4
Lymphoma, Large-Cell, Anaplastic
4
Neuroblastoma
3
Neoplasms
2
Hematologic Neoplasms
2
Carcinoma
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Neurofibromatosis 2
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Lobular
1
Carcinoma, Large Cell
1
Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
1
Advanced Cancer
1
Adenocarcinoma of Lung
1
Adenocarcinoma
1
ALK-positive NSCLC
1
ALK or ROS1-positive NSCLC
1
Interventions
pazopanib
2
cediranib
2
Sunitinib
2
Ifosfamide
2
Doxorubicin
2
sargramostim
1
romidepsin
1
pembrolizumab
1
indolepropanol phosphate
1
cabozantinib
1
atropine sulfate-diphenoxylate hydrochloride drug combination
1
Watchful Waiting
1
Warfarin
1
Vitamin B 6
1
Thyroxine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Pyridoxine
1
Promethazine
1
Prochlorperazine
1
Polymerase Chain Reaction
1
Petrolatum
1
Observation
1
Neoadjuvant Therapy
1
Lorazepam
1
Loperamide
1
HhAntag691
1
Gene Expression Profiling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Alveolar Soft Part
×
Crizotinib
×
Clear all
No trials found.